Biotech · Private company
DBV Technologies
Track this companyFree. Adds DBV Technologies to your Dealase workspace and tells you when its record changes.
Clinical trials133 recruiting or active
Pipeline programs16From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline16
- DBV712Phase 3 · Allergy, PeanutClinicalTrials.gov · fetched Nov 12, 2026
- DBV712 250 mcgPhase 3 · AllergyClinicalTrials.gov · fetched Nov 12, 2026
- DBV712 250 mcgPhase 3 · Peanut AllergyClinicalTrials.gov · fetched Nov 12, 2026
- Part A Viaskin Peanut 100 mcgPhase 3 · Peanut AllergyClinicalTrials.gov · fetched Nov 12, 2026
- Part A Viaskin Peanut 250 mcgPhase 3 · Peanut AllergyClinicalTrials.gov · fetched Nov 12, 2026
- Part B Viaskin Peanut 250 mcgPhase 3 · Peanut AllergyClinicalTrials.gov · fetched Nov 12, 2026
- Viaskin Peanut 250mcgPhase 3 · Peanut AllergyClinicalTrials.gov · fetched Nov 12, 2026
- Viaskin Peanut 250µgPhase 3 · Peanut AllergyClinicalTrials.gov · fetched Nov 12, 2026
- DBV1605Phase 2 · Cow's Milk AllergyClinicalTrials.gov · fetched Nov 12, 2026
- Viaskin Milk 150 mcgPhase 2 · Food AllergyClinicalTrials.gov · fetched Nov 12, 2026
- Viaskin Milk 300 mcgPhase 2 · Food AllergyClinicalTrials.gov · fetched Nov 12, 2026
- Viaskin Milk 500 mcgPhase 2 · Food AllergyClinicalTrials.gov · fetched Nov 12, 2026
- Viaskin Peanut 100 mcgPhase 2 · Peanut AllergyClinicalTrials.gov · fetched Nov 12, 2026
- Viaskin Peanut 250 mcgPhase 2 · Peanut AllergyClinicalTrials.gov · fetched Nov 12, 2026
- Viaskin Peanut 50 mcgPhase 2 · Peanut AllergyClinicalTrials.gov · fetched Nov 12, 2026
- DBV712 IHRPPhase 1 · Peanut AllergyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials13
- Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)PHASE3 · ACTIVE_NOT_RECRUITING · started Jun 24, 2025ClinicalTrials.gov NCT07003919 · fetched Nov 12, 2026
- Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of AgePHASE3 · ACTIVE_NOT_RECRUITING · started Feb 21, 2023ClinicalTrials.gov NCT05741476 · fetched Nov 12, 2026
- Diagnostic Accuracy and Safety of DBV1605 for the Diagnosis of Non-IgE Mediated Cow's Milk Allergy in ChildrenPHASE2 · UNKNOWN · started Aug 28, 2020ClinicalTrials.gov NCT04492683 · fetched Nov 12, 2026
- Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young ChildrenPHASE3 · COMPLETED · started Dec 6, 2018ClinicalTrials.gov NCT03859700 · fetched Nov 12, 2026
- A Study to Assess the Biological Potency of Peanut Allergen Extract in Adolescent and Adult Peanut Allergic SubjectsPHASE1 · COMPLETED · started Nov 24, 2017ClinicalTrials.gov NCT03352726 · fetched Nov 12, 2026
- Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of AgePHASE3 · COMPLETED · started Jul 31, 2017ClinicalTrials.gov NCT03211247 · fetched Nov 12, 2026
- Follow-up of the PEPITES Study to Evaluate Long-term Efficacy and Safety of Viaskin Peanut in ChildrenPHASE3 · ACTIVE_NOT_RECRUITING · started Jan 23, 2017ClinicalTrials.gov NCT03013517 · fetched Nov 12, 2026
- Safety Study of Viaskin Peanut to Treat Peanut AllergyPHASE3 · COMPLETED · started Oct 25, 2016ClinicalTrials.gov NCT02916446 · fetched Nov 12, 2026
- Efficacy and Safety of Viaskin Peanut in Children With Immunoglobulin E (IgE)-Mediated Peanut AllergyPHASE3 · COMPLETED · started Dec 1, 2015ClinicalTrials.gov NCT02636699 · fetched Nov 12, 2026
- Efficacy and Safety of Viaskin Milk in Children With IgE-Mediated Cow's Milk AllergyPHASE1_PHASE2 · COMPLETED · started Nov 1, 2014ClinicalTrials.gov NCT02223182 · fetched Nov 12, 2026
- Follow-up of the VIPES Study to Evaluate Efficacy and Safety of Viaskin Peanut in Adults and ChildrenPHASE2 · COMPLETED · started Sep 1, 2013ClinicalTrials.gov NCT01955109 · fetched Nov 12, 2026
- Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut AllergyPHASE2 · COMPLETED · started Aug 1, 2012ClinicalTrials.gov NCT01675882 · fetched Nov 12, 2026
- Expanded Access Protocol of Viaskin® Peanut (DBV712) in Peanut-allergic ChildrenAVAILABLEClinicalTrials.gov NCT05424731 · fetched Nov 12, 2026